Abstract:In a consecutive hospital-based autopsy series, we examined the relationship between apolipoprotein E (apoE) and Alzheimer's disease (AD) and investigated the clinicopathological relationship in AD. The study population included 99 patients (mean age 81 years) with AD-related neuropathological findings at death, of whom 83 were diagnosed with AD according to the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) classification, and a control group of patients without neurodegenerative disease (n = 1429). The patients were apoE genotyped and the density of β-amyloid senile plaques, neuritic plaques and neurofibrillary tangles was estimated in the cortex and hippocampus. The utility of immunohistochemical staining using an antibody directed against apoE4 in paraffin-embedded tissue was also evaluated. Among patients with "definite AD" according to CERAD, 65 % were ε4 carriers, compared to 32 % among controls (p < 0.001). The risk of ε4 carriers to develop AD was higher (odds ratio = 4.65, p = 0.001) than for non-ε4 carriers. The amount of β-amyloid deposition and neurofibrillary pathology differed significantly (p < 0.01) between the genotypes, with increasing densities from ε2 carriers to homozygous ε4 carriers. The effect of ε4 on the presence of clinical symptoms was attenuated and non-significant after adjusting for AD-related neuropathological findings. There was an association between these findings and the presence of clinical symptoms of AD, with neurofibrillary tangles separating patients with and without symptoms of AD markedly better than β-amyloid. In addition, we found a strong relationship between genotype and immunohistochemical apoE4-staining intensity. In conclusion, this Scandinavian autopsy study shows that the apoE polymorphism is associated with the probability of AD and influences the deposition of β-amyloid and neurofibrillary pathology. Our findings suggest that the association between apoE and clinical manifestations of AD is mediated mainly through the neuropathological features of AD. Further, we found a relationship between AD-related findings and clinical symptoms of AD with neurofibrillary tangles associating most strongly with clinical symptoms. Finally, immunohistochemical staining in brain specimens is useful for determining ε4- or non-ε4-carrier status.

Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques

The apolipoprotein E epsilon 4 allele is not associated with early onset temporal lobe epilepsy.

The apolipoprotein E ε4 allele is not associated with early onset temporal lobe epilepsy

Apolipoprotein epsilon 3 alleles are associated with indicators of neuronal resilience

The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.

ApoE-epsilon4 is associated with reduced memory in long-standing intractable temporal lobe epilepsy

Expression of Apolipoprotein E in Alzheimer's Disease and Its Significance

Apolipoprotein E ε4 Allele was Associated With Nonlesional Mesial Temporal Lobe Epilepsy in Han Chinese Population

APOE epsilon4 is associated with postictal confusion in patients with medically refractory temporal lobe epilepsy

ApoE ɛ4 genotype and the age at onset of temporal lobe epilepsy: A case–control study and meta-analysis

APOE ε4 associates with microglial activation independently of Aβ plaques and tau tangles

Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease

Association between serum apolipoprotein E and cognitive function in Chinese patients with temporal lobe epilepsy

Effect of apolipoprotein ε4 allele on hippocampal and brain volume in intractable temporal lobe epilepsy

APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy.

Prevalence Of The Apolipoprotein E Epsilon 4 Allele In Amyloid Beta Positive Subjects Across The Spectrum Of Alzheimer'S Disease

ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy

APOE ε4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy

P4-188: apolipoprotein e ε4 allele is associated with plasma amyloid beta transport: a population-based cross-sectional study

APOE4 Promotes Tonic-Clonic Seizures, an Effect Modified by Familial Alzheimer’s Disease Mutations

Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease